CAMBRIDGE, Mass.--(www.infi.com, and will be available for 30 days following the event.)--Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) will be presenting at the J.P. Morgan 31st Annual Healthcare Conference on January 7, 2013, at 10:00 a.m. ET in San Francisco, CA. A live webcast of this Infinity presentation will be accessible on the Investors/Media section of Infinity's website at
About Infinity Pharmaceuticals, Inc.
Infinity is an innovative drug discovery and development company seeking to discover, develop and deliver to patients best-in-class medicines for diseases with significant unmet need. Infinity combines proven scientific expertise with a passion for developing novel small molecule drugs that target emerging disease pathways. Infinity’s programs focused on the inhibition of phosphoinositide-3-kinase and heat shock protein 90 are evidence of its innovative approach to drug discovery and development. For more information on Infinity, please refer to the company’s website at www.infi.com.